RaySearch Laboratories AB Stock

Equities

RAY B

SE0000135485

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 11:29:43 2024-05-31 am EDT 5-day change 1st Jan Change
147.6 SEK +1.79% Intraday chart for RaySearch Laboratories AB +4.38% +63.46%
Sales 2023 1.02B 97.12M Sales 2024 * 1.14B 108M Capitalization 5.06B 481M
Net income 2023 81M 7.7M Net income 2024 * 127M 12.07M EV / Sales 2023 3.21 x
Net Debt 2023 186M 17.64M Net Debt 2024 * 82.48M 7.84M EV / Sales 2024 * 4.53 x
P/E ratio 2023
37.9 x
P/E ratio 2024 *
40 x
Employees 388
Yield 2023
0.78%
Yield 2024 *
1.02%
Free-Float 71.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.79%
1 week+4.38%
1 month+22.39%
3 months+43.02%
6 months+51.38%
Current year+63.46%
More quotes
1 week
137.00
Extreme 137
148.80
1 month
117.60
Extreme 117.6
153.80
Current year
84.10
Extreme 84.1
153.80
1 year
55.60
Extreme 55.6
153.80
3 years
40.00
Extreme 40
153.80
5 years
40.00
Extreme 40
193.00
10 years
36.90
Extreme 36.9
274.50
More quotes
Managers TitleAgeSince
Founder 55 99-12-31
Director of Finance/CFO 55 23-07-06
Chief Tech/Sci/R&D Officer 51 00-12-31
Members of the board TitleAgeSince
Founder 79 99-12-31
Founder 55 99-12-31
Chairman 86 04-04-30
More insiders
Date Price Change Volume
24-05-31 147.6 +1.79% 106,987
24-05-30 145 +3.87% 57,879
24-05-29 139.6 +0.29% 59,257
24-05-28 139.2 +0.14% 36,349
24-05-27 139 -1.70% 35,359

Delayed Quote Nasdaq Stockholm, May 31, 2024 at 11:29 am EDT

More quotes
RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
147.6 SEK
Average target price
135 SEK
Spread / Average Target
-8.54%
Consensus

Annual profits - Rate of surprise